Angioplasty

Accarent Health's Commitment: Ensuring Equal Access to Premium Cardiovascular Care

Retrieved on: 
Thursday, October 19, 2023
Angiography, Angioplasty, Najib Roger Accar, Certification, Percutaneous coronary intervention, Transport, Myocardial infarction, Risk, Hypertension, Aortic stenosis, Hospital, National Institute for Health and Care Excellence, Patient, Death, Cardiac catheterization, Pharmaceutical industry, Nursing, MD, Health

They also are less likely than non-minority patients to receive potentially beneficial treatments such as angiography or percutaneous coronary intervention.

Key Points: 
  • They also are less likely than non-minority patients to receive potentially beneficial treatments such as angiography or percutaneous coronary intervention.
  • In addition to improved awareness and better control of hypertension in minority populations, improved access to appropriate intervention is important to addressing these disparities.
  • Accarent Health is a unified technology and care management platform granting access to pre-negotiated, fixed bundled prices for complex medical procedures and treatments, eliminating unpredictable costs and providing increased access to quality care.
  • For more information or to access these or other cardiovascular treatment options visit Accarent Health at www.accarenthealth.com.

New York’s largest health system establishes the Northwell Cardiovascular Institute to transform heart care

Retrieved on: 
Tuesday, October 10, 2023
DEI (Diversity, Equity and Inclusion), Cardiology, General Health, Health, Hospitals, Health Technology, Professional Services, Health Insurance, Transfer, Diagnosis, Telehealth, Cardiovascular disease, Multimedia, Hospital, Microsoft, Teaching, MBA, Faculty, Death, Center for Emergency Medicine of Western Pennsylvania, Research, PAC, Education, COVID, MD, Northwell Health, Equity, Microsoft Teams, Libin Cardiovascular Institute, Heart, Transport, CVI, Facial muscles, Patient, Emergency medicine, North Shore University Hospital, New Yorker, Cardiac catheterization, LabWindows/CVI, Angioplasty, Cardiothoracic surgery, Nursing, Pharmaceutical industry, Management

To enhance the delivery of patient-centered cardiovascular care across its 21-hospital network, Northwell Health announced the creation of the Northwell Cardiovascular Institute (CVI) with a special focus on streamlining patient care, standardizing care delivery, research, and medical education across the health system.

Key Points: 
  • To enhance the delivery of patient-centered cardiovascular care across its 21-hospital network, Northwell Health announced the creation of the Northwell Cardiovascular Institute (CVI) with a special focus on streamlining patient care, standardizing care delivery, research, and medical education across the health system.
  • View the full release here: https://www.businesswire.com/news/home/20231010269308/en/
    Northwell Health announced the creation of the Northwell Cardiovascular Institute to enhance the delivery of patient-centered cardiovascular care across its 21-hospital network.
  • As a leader in cardiovascular disease prevention, diagnosis and treatment, Northwell is dedicated to elevating heart health among New Yorkers.
  • The mission of the Northwell CVI is to create accessible, inclusive and innovative care delivery system with a focus on the cardiovascular patient and care team.

Dr. Parul Khator Becomes First Doctor In Georgia to Use the iTrack Advance Canaloplasty Device for Glaucoma

Retrieved on: 
Tuesday, August 29, 2023
Medical Devices, Health, Health Technology, General Health, Optical, Biotechnology, Infection, Tunnel, Glaucoma, Injury, IOP, Surgeon, Headache, Trabecular meshwork, Visual impairment, Paratriathlon, Inflammation, MIGS, Intraocular pressure, Angioplasty, Patient, Risk, Humour, Optic nerve, Hospital

Georgia Eye Partners is proud to share that Dr. Parul Khator has become the first eye surgeon in Georgia to utilize the iTrack Advance Canaloplasty Device, a minimally invasive glaucoma surgical device (MIGS) used to reduce intraocular pressure (IOP) in adult patients with primary open-angle glaucoma.

Key Points: 
  • Georgia Eye Partners is proud to share that Dr. Parul Khator has become the first eye surgeon in Georgia to utilize the iTrack Advance Canaloplasty Device, a minimally invasive glaucoma surgical device (MIGS) used to reduce intraocular pressure (IOP) in adult patients with primary open-angle glaucoma.
  • The device offers a more efficient glaucoma procedure for patients and surgeons, and can be used standalone or in combination with cataract surgery to help control a glaucoma patient’s eye pressure while lessening their medication burden.
  • “I am constantly looking for minimally invasive treatment options for my patients that can deliver good results with less risk,” said Dr. Parul Khator, Georgia Eye Partners ophthalmologist and glaucoma specialist.
  • Georgia Eye Partners remains committed to serving patients throughout Greater Atlanta and Georgia by implementing the latest and greatest advanced glaucoma technologies and procedures.

Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis

Retrieved on: 
Tuesday, August 8, 2023
SAB, Ohio State University, Orchestra, Partnership, Institutional review board, HOPE, Virtue, FACC, ISR, Sirolimus, SABRE, Medicine, Angioplasty, Patient, Christ Hospital, IDE, Coronary artery disease, Principal, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Safety, Pharmaceutical industry, POBA, Terumo

“We believe that Virtue SAB has the potential to address a significant unmet clinical need and improve outcomes for a patient population with suboptimal treatment options.

Key Points: 
  • “We believe that Virtue SAB has the potential to address a significant unmet clinical need and improve outcomes for a patient population with suboptimal treatment options.
  • “This IDE approval and forthcoming pivotal study reflect our commitment to accelerating innovation through our differentiated, partnership-enabled business model.
  • The Virtue ISR-US pivotal study is a randomized, prospective, double-blind, multi-center, controlled study of Virtue SAB vs.
  • The conditional approval also requires the Company to submit additional information to the FDA.

Connecticut's Chief Manufacturing Officer Paul Lavoie Visits Radcliff Wire, Shares Workforce Initiatives

Retrieved on: 
Friday, June 30, 2023
COVID, Workforce, Central Connecticut State University, University, Angioplasty, CT, Ecosystem, Radcliffe, Tunxis Community College, Lean, Medical device, Nursing, BRISTOL

BRISTOL, Conn., June 30, 2023 /PRNewswire-PRWeb/ -- Connecticut's Chief Manufacturing Officer Paul Lavoie toured Radcliff Wire Inc. of Bristol, CT June 12, 2023. The visit was part of the "L4" tour Lavoie launched last year. He initiated the Lean-in, Listen, Learn, and Link (L4) tour as a tactic to support his objective to "relentlessly" communicate with all of Connecticut's manufacturing stakeholders to discuss their concerns, challenges, and needs.

Key Points: 
  • During a recent visit to Radcliff Wire, the CT's Chief Manufacturing Officer, Paul Lavoie, and Charlie Radcliff, President of Radcliff Wire Inc., talked about workforce and supply chain challenges.
  • BRISTOL, Conn., June 30, 2023 /PRNewswire-PRWeb/ -- Connecticut's Chief Manufacturing Officer Paul Lavoie toured Radcliff Wire Inc. of Bristol, CT June 12, 2023.
  • Lavoie's visit to Radcliff Wire was one of countless company visits he's conducted since assuming the role of Chief Manufacturing Officer in February of 2022.
  • "During the pandemic, delivery became the new currency, not price," said Paul Lavoie, CT's Chief Manufacturing Officer.

Allegheny Health Network Names Akshay Khandelwal, MD, System Chair of the Department of Cardiovascular Medicine

Retrieved on: 
Thursday, June 15, 2023
Henry Ford Health, University, Education, Wayne State University, Bangalore University, American College of Cardiology, American Board of Internal Medicine, Heart, Khandelwal, Cardiovascular disease, FACC, Sri Devaraj Urs Academy of Higher Education and Research, University Law College, Bangalore University, Business, MBA, Research, Allegheny General Hospital, Cardiology, Libin Cardiovascular Institute, Edith, Thought, American Board of Commissioners for Foreign Missions, Business administration, Hospital, Angioplasty, AHN, Henry Ford, MD, Patient, Physician, Internal medicine, Wayne, American College, Allegheny Health Network, Henry Ford Hospital, University of Tennessee College of Medicine, National Association Medical Staff Services, Management, Medical device, Medical imaging, Nursing

PITTSBURGH, June 15, 2023 /PRNewswire-PRWeb/ -- Akshay Khandelwal, MD, MBA, FACC, FSCAI, an interventional cardiologist and physician leader with the Henry Ford Health system, has been named Chair of the Department of Cardiovascular Medicine at Allegheny Health Network (AHN).

Key Points: 
  • Akshay Khandelwal, MD, MBA, FACC, FSCAI, an interventional cardiologist and physician leader with the Henry Ford Health system, has been named Chair of the Department of Cardiovascular Medicine at Allegheny Health Network.
  • PITTSBURGH, June 15, 2023 /PRNewswire-PRWeb/ -- Akshay Khandelwal, MD, MBA, FACC, FSCAI, an interventional cardiologist and physician leader with the Henry Ford Health system, has been named Chair of the Department of Cardiovascular Medicine at Allegheny Health Network (AHN).
  • The Department of Cardiovascular Medicine is part of AHN's Cardiovascular Institute.
  • "It's an incredible honor to join a forward thinking, blended health organization like AHN and Highmark Health that is truly committed to transforming medicine," Dr. Khandelwal said.

Peijia Medical Records Revenue Growth of 83.7% Year-over-Year in 2022

Retrieved on: 
Monday, April 3, 2023
Marketing, TR, Stroke, Hospital, Patent, Patient, Angioplasty, National Medical Products Administration, TAVR, R, Greater, Research, Accounting, Growth, NMPA, Technology transfer, AR, D, COVID-19, Generator, Balloon, Journal of NeuroInterventional Surgery, Partnership, CE marking, Clinical trial, Highlife, FIM, Medical device, Pharmaceutical industry, Video game, PRC

During the Year, the Group realized revenue of RMB250.8 million, an increase of 83.7% over the same period in 2021.

Key Points: 
  • During the Year, the Group realized revenue of RMB250.8 million, an increase of 83.7% over the same period in 2021.
  • During the Year, revenue generated from the sales of Transcatheter Valve Therapeutic products amounted to RMB107.3 million, representing a year-over-year increase of 155.9%.
  • After the initial year of commercialization in 2021, the number of hospital admissions and end-user implants continued to increase significantly in 2022.
  • With the completion and commissioning of the new headquarters in 2023, Peijia Medical will fully accelerate its product development, production and commercialization.

Nova Eye Medical Announces U.S. Market Clearance of the iTrack™ Advance Canaloplasty Device

Retrieved on: 
Wednesday, April 12, 2023
Research, Surgery, Medical Devices, FDA, Health Technology, Biotechnology, Health, Optical, Science, Glaucoma, IOP, Surgeon, University, Refractive surgery, Trabecular meshwork, University of Oklahoma, Food and Drug Administration, EYE, ASX, ASCRS, MIGS, American Society of Cataract and Refractive Surgery, Intraocular pressure, Nova, Angioplasty, Patient, Humour, CTN, Cataract, Society, Food, Safety, Medical imaging, Veterinary medicine, Advance, Ophthalmology

Nova Eye Medical Limited (ASX: EYE) (Nova Eye Medical or the Company), a medical technology company committed to advanced ophthalmic treatment technologies and devices, today announces that it has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for its new canaloplasty device, iTrack™ Advance.

Key Points: 
  • Nova Eye Medical Limited (ASX: EYE) (Nova Eye Medical or the Company), a medical technology company committed to advanced ophthalmic treatment technologies and devices, today announces that it has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for its new canaloplasty device, iTrack™ Advance.
  • Canaloplasty was first brought to the ophthalmological fore in 2008, following the release of the Company’s original iTrack™ canaloplasty microcatheter, which has been used in more than 120,000 canaloplasty procedures globally.
  • “I’ve been given the great opportunity to pair hand in hand with Nova Eye Medical to develop the iTrack™ Advance.
  • According to Tom Spurling, Managing Director of Nova Eye Medical, the Company will expand its sales and clinical teams in the U.S. effective immediately, to support the U.S. market introduction of iTrack™ Advance.

Northwell cardiac surgery, cardiology programs rank among New York’s best

Retrieved on: 
Monday, April 10, 2023
Surgery, Other Health, Hospitals, Health, Cardiology, CABG, Health department, RAMR, Multimedia, Northwell Health, Teaching hospital, PCI, North Shore University Hospital, Lenox Hill Hospital, Hospital, Angioplasty, Physician, Risk, Medical Center, Aortic valve, TAVR, Staten Island University Hospital, DOH, Mortality, LIJ, Elective surgery, Aortic stenosis, Nursing, Lenox Hill, MD, NYS

View the full release here: https://www.businesswire.com/news/home/20230410005252/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230410005252/en/
    A Northwell cardiothoracic team performs open-heart surgery.
  • Northwell’s cardiothoracic programs also were recognized for superior outcomes in several other cardiac surgery categories in the state report.
  • The state analyzed 69,065 total adult cardiac surgeries, including isolated coronary artery bypass graft (CABG), valve, valve/CABG, and other cardiac surgeries performed statewide and discharged between December 2016-November 2019.
  • “I’m incredibly proud of the accomplishments of the combined superior outcomes achieved by our cardiac teams in angioplasty and cardiothoracic surgery.

THRIVE | Coworking Officially Debuts in Charleston With Grand-Opening Event on March 30

Retrieved on: 
Tuesday, March 14, 2023
Men, Professional Services, Consumer, Commercial Building & Real Estate, Small Business, Construction & Property, Labor, Women, Urban Planning, Human Resources, Consulting, Public Policy, Government, Coworking, Organic, Snack, Restaurant, Culture, Angioplasty, Smith, Student, Commerce, Workforce, Tea, Coffee, Nightclub, Management

THRIVE | Charleston is located on the third floor at 174 Meeting St.

Key Points: 
  • THRIVE | Charleston is located on the third floor at 174 Meeting St.
    As more professionals demand to work close to home, coworking spaces are filling this need to create a healthy work/life balance while providing the physical workspace necessary for team building and mentorship.
  • “We look forward to hosting our members and guests at the grand opening and fully embracing the city of Charleston and this vibrant downtown neighborhood.”
    Smith and THRIVE Co-Founder/CEO Ramon Gonzalez will attend the event, sharing the company’s community-focused philosophy and vision for the future of THRIVE | Charleston.
  • In addition to Charleston, THRIVE | Coworking members have access to all THRIVE workspaces located around the Southeast and Midwest, as well as around the country and internationally through reciprocal use of LExC coworking spaces .
  • THRIVE | Initiative is a 501(c)(3) nonprofit that helps charities, enterprises and communities thrive through the power of generosity.